Cortical differences across psychiatric disorders and associated common and rare genetic variants

Kuldeep Kumar, Zhijie Liao, Jakub Kopál, Clara Moreau, Christopher R. K. Ching, Claudia Modenato, William C. Snyder, Sayeh Kazem, Charles-Olivier Martin, Anne-Marie Bélanger, Valérie Fontaine, Khadijé Jizi, Rune Bøen, Guillaume Huguet, Zohra Saci, Leila Kushan, Ana Isabel Silva, Marianne van den Bree, David E.j. Linden, Michael J. Owen, Jérémy Hall, Sarah Lippé, Guillaume Dumas, Bogdan Draganski, Laura Almasy, Sophia I. Thomopoulos, Neda Jahanshad, Ida E. Sønderby, Ole A. Andreassen, David C. Glahn, Armin Raznahan, Carrie E. Bearden, Tomaš Paus, Paul M. Thompson, Sébastien JacquemontmedRxiv 2025 · DOI

Abstract

Genetic studies have identified numerous common and rare variants that increase the risk for neurodevelopmental and psychiatric disorders (NPDs). While these variants are known to influence cortical structure, it remains unclear whether the cortical differences observed in clinical populations are directly attributable to this underlying genetic risk. This study analyzed cortical thickness (CT) and surface area (SA) data from approximately 33,000 individuals, comparing the effects of common and rare genetic variants against the clinical signatures of eight major NPDs. The findings reveal a fundamental dissociation: genetic risk variants primarily influence total SA in sensorimotor regions, whereas clinical diagnoses are characterized by differences in mean CT within higher-order association areas. These results suggest that the cortical signatures of psychiatric disorders may be driven more by non-genetic factors, such as medication and the lived experience of the disorder, than by the primary genetic risk factors themselves.

Introduction

A central goal in biological psychiatry is to map the path from genetic risk to clinical manifestation. While neurodevelopmental and psychiatric disorders (NPDs) are highly heritable, connecting specific genetic variants to the brain structural changes seen in patients has proven difficult. This study addresses this gap by systematically comparing the "neuroimaging signatures" of genetic risk—encompassing both common single-nucleotide polymorphisms (SNPs) and rare copy number variations (CNVs)—with the actual brain signatures observed in clinical cohorts across eight major conditions.

Methodology and Data Sources

The researchers utilized a massive multi-cohort dataset to compare effect sizes (Cohen’s d) across two primary global metrics: Cortical Thickness (CT) and Surface Area (SA). The analysis integrated data from:

  • The ENIGMA Consortium: Providing summary statistics for eight NPDs, including ADHD, Autism, Bipolar Disorder, Major Depression, and Schizophrenia.
  • The UK Biobank: Data from ~31,000 participants for common and rare variant analysis.
  • Rare Variant Cohorts: Specific datasets for 18 rare genetic events, including 16p11.2 and 22q11.2 deletions/duplications and sex chromosome aneuploidies.

To contextualize regional findings, the team employed "consensus mapping" and analyzed results against the sensorimotor-to-association cortical gradient, which ranks brain regions from basic sensory processing to higher-order cognition.

Key Findings

The Global Metric Dissociation

The study identified a striking "mismatch" between genetic influence and clinical phenotype. Genetic risk (both rare and common) is predominantly a "Surface Area" story. Rare variants, in particular, showed an 11-fold larger effect on SA than clinical diagnoses. Conversely, clinical NPD diagnoses are primarily associated with changes in Cortical Thickness. This suggests that the biological processes governed by risk genes (largely influencing SA) are distinct from the processes characterizing the manifest disorder (largely influencing CT).

Opposing Spatial Gradients

When examining regional patterns, genetic variants and clinical disorders hit different parts of the brain. Genetic variants showed strong negative correlations with the cortical gradient, meaning their impact is most pronounced in sensorimotor regions (the brain's primary inputs and outputs). In contrast, psychiatric disorders showed positive correlations with the gradient, with the greatest effects observed in association regions—the areas responsible for complex cognition, language, and social behavior.

The Polygenic Cancellation Effect

A significant puzzle in psychiatric imaging is why polygenic risk scores (PRS) often fail to show clear brain signatures. The authors discovered a "cancellation effect": for disorders like schizophrenia, approximately half of the risk-associated SNPs increase SA while the other half decrease it. When aggregated in an additive polygenic model, these opposing effects cancel each other out, resulting in a negligible global signal despite significant underlying genetic influence.

The Impact of Non-Genetic Factors

The study found that the observed CT changes in patients were 3.4-fold larger in medicated subgroups compared to unmedicated ones. This suggests that the "brain signature" of a disorder recorded in clinical studies may be heavily influenced by treatment and the long-term experience of the illness, rather than being a direct reflection of the genetic blueprint.

Discussion and Implications

These results suggest a developmental decoupling. Surface area is largely established in early childhood and appears more sensitive to genetic programming. Cortical thickness matures later and remains more plastic throughout adulthood, potentially making it more susceptible to environmental factors, disease progression, and pharmacological intervention.

Future research should focus on pediatric populations to determine if genetic signals in surface area are more detectable before the confounding effects of medication and lived experience emerge. Understanding this divergence is critical for developing biomarkers that accurately distinguish between the innate risk for a disorder and the secondary effects of the condition itself.

Summary updated

Abstract

Genetic studies have identified common and rare variants increasing the risk for neurodevelopmental and psychiatric disorders (NPDs). These risk variants have also been shown to influence the structure of the cerebral cortex. However, it is unknown whether cortical differences associated with genetic variants are linked to the risk they confer for NPDs. To answer this question, we analyzed cortical thickness (CT) and surface area (SA) for common and rare variants associated with NPDs, in ~33000 individuals from the general population and clinical cohorts, as well as ENIGMA summary statistics for 8 NPDs. Rare and common genetic variants increasing risk for NPDs were preferentially associated with total SA, while NPDs were preferentially associated with mean CT. Larger effects on mean CT, but not total SA, were observed in NPD medicated subgroups. At the regional level, genetic variants were preferentially associated with effects in sensorimotor areas, while NPDs showed higher effects in association areas. We show that schizophrenia- and bipolar-disorder-associated SNPs show positive and negative effect sizes on SA suggesting that their aggregated effects cancel out in additive polygenic models. Overall, CT and SA differences associated with NPDs do not relate to those observed across individual genetic variants and may be linked with critical non-genetic factors, such as medication and the lived experience of the disorder.
BibTeX
@misc{kumar2025cortical,
  author = {Kuldeep Kumar and Zhijie Liao and Jakub Kopál and Clara Moreau and Christopher R. K. Ching and Claudia Modenato and William C. Snyder and Sayeh Kazem and Charles-Olivier Martin and Anne-Marie Bélanger and Valérie Fontaine and Khadijé Jizi and Rune Bøen and Guillaume Huguet and Zohra Saci and Leila Kushan and Ana Isabel Silva and Marianne van den Bree and David E.J. Linden and Michael J. Owen and Jérémy Hall and Sarah Lippé and Guillaume Dumas and Bogdan Draganski and Laura Almasy and Sophia I. Thomopoulos and Neda Jahanshad and Ida E. Sønderby and Ole A. Andreassen and David C. Glahn and Armin Raznahan and Carrie E. Bearden and Tomaš Paus and Paul M. Thompson and Sébastien Jacquemont},
  title = {{Cortical differences across psychiatric disorders and associated common and rare genetic variants}},
  year = {2025},
  doi = {10.1101/2025.04.16.25325971},
  howpublished = {medRxiv},
}
Figure